Skip to main content
. 2022 Jul 12;10(4):e002738. doi: 10.1136/bmjdrc-2021-002738

Table 3.

Adjusted HRs of A1c TIR predicting incident macrovascular complications

Main predictor Macrovascular
(n=89 625)
Cardiovascular
(n=122 135)
Cerebrovascular
(n=277 234)
Peripheral vascular (n=228 583)
A1c TIR * * * *
 80% to 100% 1.00 1.00 1.00 1.00
 60% to <80% 1.05* (1.02–1.08) 1.02 (0.99–1.05) 1.05* (1.02–1.08) 1.09* (1.06–1.13)
 40% to <60% 1.03* (1.00–1.06) 1.01 (0.99–1.04) 1.08* (1.05–1.11) 1.09* (1.05–1.12)
 20% to <40% 1.05* (1.02–1.08) 1.05* (1.02–1.08) 1.07* (1.04–1.10) 1.09* (1.06–1.12)
 0% to <20% 1.08* (1.05–1.11) 1.08* (1.05–1.11) 1.09* (1.07–1.12) 1.12* (1.09–1.15)
A1c SD 1.00 (0.98–1.03) 1.00 (0.98–1.02) 0.98 (0.97–1.00) 0.99 (0.97–1.01)
A1c mean 1.05* (1.04–1.06) 1.05* (1.04–1.06) 1.08* (1.07–1.09) 1.11* (1.10–1.12)

*P<0.05.

A1c, hemoglobin A1c; TIR, time in range.